Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CD80 Antikörper

Dieses Kaninchen Chimeric-Antikörper erkennt spezifisch CD80 in ELISA und BR. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7072690

Kurzübersicht für Rekombinanter CD80 Antikörper (ABIN7072690)

Target

Alle CD80 Antikörper anzeigen
CD80

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 188
  • 110
  • 46
  • 8
  • 6
  • 6
  • 1
  • 1
  • 1
Human

Wirt

  • 112
  • 97
  • 22
  • 21
  • 18
  • 2
  • 1
Kaninchen

Klonalität

  • 190
  • 81
  • 1
Chimeric

Konjugat

  • 105
  • 25
  • 19
  • 16
  • 12
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CD80 Antikörper ist unkonjugiert

Applikation

  • 144
  • 96
  • 73
  • 40
  • 39
  • 26
  • 14
  • 13
  • 13
  • 13
  • 11
  • 10
  • 9
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Blocking Reagent (BR)

Klon

16C10
  • Verwendungszweck

    Anti-CD80 [16C10], Rabbit IgG, lambda

    Spezifität

    This antibody binds human CD80 and inhibits the B7.1:CD28 pathway.

    Produktmerkmale

    Original Species of Ab: Rhesus Macaque

    Original Format of Ab: IgG1

    Aufreinigung

    Protein A affinity purified

    Immunogen

    This antibody was generated by immunization of cynomolgus monkeys with human B7.1 antigen.

    Isotyp

    IgG lambda
  • Applikationshinweise

    This antibody can be used for identification of human B7.1 antigen and is capable of inhibiting the binding of B7.1 to CD28, however it does not block the binding of B7.1 to CTLA-4. This antibody further inhibits the production of IL-2. Blocking of the primary activation signal between CD28 and B7.1 (CD80) with these antibodies while allowing the unimpaired or coincident interaction of CTLA-4 and B7.1 represents a combined antagonistic effect on positive co-stimulation with an agonistic effect on negative signaling. The binding of the antibody to soluble B7.1 was tested using ELISA. This antibody tested positive for binding to human C1q protein. This antibody is reported to cause keratinocyte hyperproliferation and decrease in psoriasis by inhibiting the B7:CD28 pathway. This antibody is further reported to be useful for the treatment of intestinal inflammation and rheumatoid arthritis.

    Kommentare

    This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    CD80

    Andere Bezeichnung

    CD80

    Hintergrund

    B7.1, CD28L, CD28LG, B7-1, B7, BB1, B7/BB1,T-lymphocyte activation antigen CD80, Activation B7-1 antigen, CTLA-4 counter-receptor B7.1, CTLA4L, CTLA-4L

    UniProt

    P33681

    Pathways

    T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Sie sind hier:
Chat with us!